Wealth Enhancement Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1M | Sell |
203,983
-24,166
| -11% | -$1.67M | 0.02% | 527 |
|
|
2025
Q1 | $15.8M | Sell |
228,149
-52,664
| -19% | -$3.66M | 0.03% | 461 |
|
|
2024
Q4 | $24.2M | Sell |
280,813
-8,625
| -3% | -$742K | 0.05% | 334 |
|
|
2024
Q3 | $34.5M | Buy |
289,438
+37,346
| +15% | +$4.45M | 0.07% | 254 |
|
|
2024
Q2 | $36M | Buy |
252,092
+46,394
| +23% | +$6.62M | 0.09% | 221 |
|
|
2024
Q1 | $26.4M | Buy |
205,698
+98,007
| +91% | +$12.6M | 0.07% | 270 |
|
|
2023
Q4 | $11.1M | Buy |
107,691
+9,868
| +10% | +$1.02M | 0.03% | 408 |
|
|
2023
Q3 | $8.9M | Buy |
97,823
+88,975
| +1,006% | +$8.09M | 0.03% | 437 |
|
|
2023
Q2 | $716K | Sell |
8,848
-2,036
| -19% | -$165K | 0.01% | 309 |
|
|
2023
Q1 | $866K | Buy |
+10,884
| New | +$866K | 0.01% | 321 |
|